1 We repeated analyses for Alzheimer disease and accounting for
2 We repeated analyses using linear mixed models to examine ass
3 To compare with pharmacological inhibition of eNOS,
we repeated both tests in the presence of l-NAME.
4 enrichment is greatest in transposon-dense heterochromatin,
we repeated ChIP-seq in kyp suvh5 suvh6 H3K9me2 mutants.
5 We repeated each external noise sequence twice, and assessed
6 We repeated our analyses after stratifying hospitals into qui
7 Because L-DOPA effects may be influenced by body weight,
we repeated our analyses on data from half of the sample (n =
8 might indicate abnormal weakening of response gain control,
we repeated our measurements at low contrast, where the effec
9 We repeated propensity score-matching according to the hemogl
10 18 months after VISHRAM was enacted,
we repeated sampling methods to select a separate population
11 We repeated TFdi,max measurements within 24 hours of extubati
12 We repeated the above analysis for variation in diastolic blo
13 To verify these associations,
we repeated the analyses with an independent set of behaviora
14 We repeated the analysis for the subset of patients with infe
15 To simulate data limitations,
we repeated the analysis using a single criterion at a time (
16 For significant findings,
we repeated the analysis using intake estimates from modified
17 ta suitable for comparison with data of denatured proteins,
we repeated the assignment in 7 M urea (pH 2.3) and in DMSO.
18 We repeated the behavioral portions of these studies in wild-
19 We repeated the experiment from three homing sites using mult
20 Second,
we repeated the experiments by substituting phosphatidylserin
21 In this study,
we repeated the experiments to ensure that the high variance
22 When
we repeated the experiments with C3-deficient mice, we observ
23 r ischemia affects the systemic immune response to antigen,
we repeated the immunization experiment using mice deficient
24 We repeated the original experiments separately in three diff
25 Finally,
we repeated the pretraining and pretesting experiments with t
26 Supporting this finding,
we repeated the primary analysis in a cohort of patients not
27 We repeated the process for those with >/=2 samples within 28
28 When
we repeated the same visual stimulus, we found that the same
29 We repeated the sensitivity analysis with Xpert MTB/RIF as th
30 tion types from the tropics to the northern high-latitudes,
we repeated the site and global simulations using two reanaly
31 We repeated the standardized cognitive test battery after a m
32 xplore these puzzling effects and their mechanisms further,
we repeated the tests for RI associated with diet-specific gu
33 We repeated these analyses among networks offered in the same
34 We repeated these analyses by type of immunocompromising cond
35 We repeated these analyses by type of immunocompromising cond
36 To assess for construct validity,
we repeated these analyses in a subset of patients with docum
37 We repeated these analyses stratifying by age.
38 We repeated these analyses using TV-viewing time instead of d
39 We repeated these at the 6-year follow-up alongside venous bl
40 l effects in the presence of significant amyloid pathology,
we repeated these experiments in older APP/PS1 mice with sign
41 To assess the reproducibility of the diagnosis,
we repeated these measurements after 4 weeks.
42 might be achieved across a variable population of animals,
we repeated this analysis across six sets of maximal conducta
43 We repeated this analysis after adjustment with both small si
44 We repeated this analysis for ICD subtypes: single chamber, d
45 enome sequencing and evolutionary convergence analysis, and
we repeated this analysis in an independent validation cohort
46 We repeated this analysis using genetic variants independent
47 We repeated this analysis, adding the peak TnT measurement du
48 To prevent DA activation of D4 receptors,
we repeated this experiment in LHb slices from DA-depleted ra
49 We repeated this process on 22 colorectal cell lines and foun
50 Here, using a superior 5-HTT tracer, (11)C-DASB,
we repeated this study with a prospective design with 8 wk of